880346 | DChemsPC
1,2-dicholesterylhemisuccinoyl-sn-glycero-3-phosphocholine

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
DChemsPC
1,2-dicholesterylhemisuccinoyl-sn-glycero-3-phosphocholine
Cholesterol exchange is a major reason for the instability of liposomes in blood. The formation of a covalent hybrid between cholesterol and glycerophosphocholine preserves the bilayer-stabilizing effect of free cholesterol but prevents its transfer from the bilayer. Thus, disterolphospholipids are valuable new components for liposome formulation.
CAS Registry Number is a Registered Trademark of the American Chemical Society
Flasiński M, Konderla B, Broniatowski M, Wydro P. Sterol-Phospholipid Hybrids at the Air/Water Interface: Studies on Properties and Interactions with Parent Lipid Molecules. Langmuir. 2016 Apr 26;32(16):4095-102. doi: 10.1021/acs.langmuir.5b04311. Epub 2016 Apr 13. PMID: 27046325.
PubMed ID: 27046325Foglia F, Barlow DJ, Szoka FC, Huang Z, Rogers SE, Lawrence MJ. Structural studies of the monolayers and bilayers formed by a novel cholesterol-phospholipid chimera. Langmuir. 2011 Jul 5;27(13):8275-81. doi: 10.1021/la200739y. Epub 2011 Jun 2. PMID: 21634402.
PubMed ID: 21634402Iman M, Huang Z, Szoka FC Jr, Jaafari MR. Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a di-stigma-steryl-hemi-succinoyl-glycero-phosphocholine liposome-intercalated amphotericin B. Int J Pharm. 2011 Apr 15;408(1-2):163-72. doi: 10.1016/j.ijpharm.2011.01.044. Epub 2011 Jan 26. PMID: 21277963; PMCID: PMC3071037.
PubMed ID: 21277963Huang Z, Szoka FC Jr. Sterol-modified phospholipids: cholesterol and phospholipid chimeras with improved biomembrane properties. J Am Chem Soc. 2008 Nov 19;130(46):15702-12. doi: 10.1021/ja8065557. Epub 2008 Oct 25. PMID: 18950160; PMCID: PMC2701441.
PubMed ID: 18950160A summary of the physical/chemical properties of Sterol-Modified Phospholipids is presented in a PowerPoint presentation. This information was kindly provided by Dr. Francis C. Szoka, Jr., Department of Biopharmaceutical Sciences, University of California, San Francisco, California.
- Certificate of Analysis (Lot No. 880346P-25MG-A-011 and 6321PJA011)
- Certificate of Analysis (Lot No. 880346P-25MG-B-011 and 6321PJB011)
- Certificate of Analysis (Lot No. 880346P-25MG-C-011 and 6321PJC011)
- Certificate of Analysis (Lot No. 880346P-25MG-D-011 and 6321PJD011)
- Certificate of Analysis (Lot No. 880346P-25MG-E-011 and 6321PJE011)
- Certificate of Analysis (Lot No. 880346P-25MG-F-011 and 6321PJF011)